Testing effectiveness (Phase 2)Looking for participantsNCT07237100
What this trial is testing
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
Who this might be right for
Advanced Unresectable MelanomaMetastatic Melanoma
Kevin Kim, MD 10
Showing 10 of 10 results